Cargando…

Ligelizumab treatment for severe asthma: learnings from the clinical development programme

OBJECTIVE: Ligelizumab is a humanised IgG1 anti‐IgE antibody that binds IgE with higher affinity than omalizumab. Ligelizumab had greater efficacy than omalizumab on inhaled and skin allergen provocation responses in mild allergic asthma. This multi‐centre, randomised, double‐blind study was designe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trischler, Jordis, Bottoli, Ivan, Janocha, Reinhold, Heusser, Christoph, Jaumont, Xavier, Lowe, Phil, Gautier, Aurelie, Pethe, Abhijit, Woessner, Ralph, Zerwes, Hans‐Günter, Zielen, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958305/ https://www.ncbi.nlm.nih.gov/pubmed/33747510 http://dx.doi.org/10.1002/cti2.1255

Ejemplares similares

The rationale for development of ligelizumab in food allergy
por: Wood, Robert A., et al.
Publicado: (2022)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
por: Arm, J P, et al.
Publicado: (2014)

Hospitalization, Asthma Phenotypes, and Readmission Rates in Pre-school Asthma
por: Donath, Helena, et al.
Publicado: (2020)

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
por: Zielen, Stefan, et al.
Publicado: (2021)

The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
por: Gasser, Pascal, et al.
Publicado: (2020)

Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System
por: Ji, Yan, et al.
Publicado: (2023)

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria()
por: Metz, Martin, et al.
Publicado: (2022)

Fractionated breath condensate sampling: H(2)O(2 )concentrations of the alveolar fraction may be related to asthma control in children
por: Trischler, Jordis, et al.
Publicado: (2012)

A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma
por: Fussbroich, D., et al.
Publicado: (2019)

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms
por: Kuo, Be-Sheng, et al.
Publicado: (2022)

Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma
por: Hanania, Nicola A., et al.
Publicado: (2022)

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
por: Menzella, Francesco, et al.
Publicado: (2023)

Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis
por: Donath, H., et al.
Publicado: (2023)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Efficacy predictors of omalizumab in Chinese patients with moderate-to-severe allergic asthma: Findings from a post-hoc analysis of a randomised phase III study()
por: Li, Jing, et al.
Publicado: (2020)

National and regional asthma programmes in Europe
por: Selroos, Olof, et al.
Publicado: (2015)

Pediatric asthma: An unmet need for more effective, focused treatments
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2018)

Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence
por: Wollenberg, Andreas, et al.
Publicado: (2021)

The "Triple Helix" of space: German space activities in a European perspective
por: Trischler, H
Publicado: (2002)

Cell distribution and cytokine levels in induced sputum from healthy subjects and patients with asthma after using different nebulizer techniques
por: Koc-Günel, Sinem, et al.
Publicado: (2018)

Sublingual immunotherapy provides long‐term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real‐world database analysis
por: Zielen, S., et al.
Publicado: (2017)

Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury
por: Goldklang, Monica P., et al.
Publicado: (2019)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
por: Brittain, Dominic, et al.
Publicado: (2022)

Arginine metabolic endotypes related to asthma severity
por: Xu, Weiling, et al.
Publicado: (2017)

Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge
por: Schulze, Johannes, et al.
Publicado: (2012)

Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for Heartburn
por: Vakil, Nimish, et al.
Publicado: (2008)

Pulmonary remodeling in asthma
por: Lieberman, Phil
Publicado: (2010)

Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial
por: Rose, Markus A, et al.
Publicado: (2011)

Mejora del valor añadido en los procesos : ahorrando tiempo y dinero eliminando despilfarro /
por: Trischler, William E., 1939-
Publicado: (1998)

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results
por: Maurer, Marcus, et al.
Publicado: (2020)

A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA
por: Fussbroich, D., et al.
Publicado: (2020)

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
por: Chapman, Kenneth, et al.
Publicado: (2021)

Interpersonal Violence in Belgian Sport Today: Young Athletes Report
por: Vertommen, Tine, et al.
Publicado: (2022)

Engineered bacteriophages as programmable biocontrol agents
por: Huss, Phil, et al.
Publicado: (2020)

Environmental triggers and avoidance in the management of asthma
por: Gautier, Clarisse, et al.
Publicado: (2017)

Chasing Behavior and Optomotor Following in Free-Flying Male Blowflies: Flight Performance and Interactions of the Underlying Control Systems
por: Trischler, Christine, et al.
Publicado: (2010)

Conference "The Cultural Alchemy of the Exact Sciences : Revisiting the Forman Thesis"
por: Carson, Cathryn, et al.
Publicado: (2011)

Crystal structure of ammonium bis[(pyridin-2-yl)methyl]ammonium dichloride
por: Trischler, Aaron, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kgcgb2v47nbk2qnfd1fgc0g447